Sonnet BioTherapeutics Holdings, Inc. earnings per share and revenue

SONN earnings per share for the last quarter are -0.31 USD whereas the estimation was -0.62 USD which accounts for 50.40% surprise. Företagets omsättning för samma period uppgår till 18.60 k USD trots den uppskattade siffran 27.50 k USD. Estimated earnings per share for the next quarter are -0.70 USD, and revenue is expected to reach 12.33 k USD. Also watch annual changes over time to get a bigger picture of SONN earnings per share and revenue dynamics.